aDepartment of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany bDeutsches Zentrum ...

The US Food and Drug Administration (FDA) has approved Zevaskyn, the first cell-based gene therapy for a rare genetic skin disorder called recessive dystrophic epidermolysis bullosa. Developed by ...

The disorder — known as Stevens-Johnson syndrome — first took hold ... “You get these lesions that show up all of your skin, and it was the worst in my mouth. “It really was emotional ...

Senescent skin cells—sometimes dubbed “zombie cells”—have long posed a paradox. These cells, which stop dividing yet refuse to die, can aid in wound healing and immune responses but also ...

Senescent skin cells, often referred to as zombie cells because they have outlived their usefulness without ever quite dying, have existed in the human body as a seeming paradox, causing ...

Senescent skin cells, often referred to as zombie cells because they have outlived their usefulness without ever quite dying, have existed in the human body as a seeming paradox, causing inflammation ...

Senescent skin cells, often referred to as zombie cells because they have outlived their usefulness without ever quite dying, have existed in the human body as a seeming paradox, causing ...

The novel in vitro assay measured β-hexosaminidase release as a functional readout of mast cell activation. To test the assay, the researchers exposed human LAD2 mast cells to a panel of nanoparticles ...

Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University Atlanta, Atlanta, Georgia 30322, United States ...

These factors can activate mast cells ... psoriatic lesion and therefore a feedforward loop can exist, promoting inflammation. Animal models have shown mast cell activation in the skin through ...